Key facts
- This page summarizes Samuel C. Wadsworth's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 May 2024, 16:26.
Samuel C. Wadsworth - 04 May 2024 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- Director
- Issuer ticker
- DTIL
- Reported as of
- 04 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 May 2024, 16:26:03 UTC
- Prior SEC filing
- 08 May 2023
- Next SEC filing
- 06 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dario Scimeca, Attorney-in-Fact for Samuel C. Wadsworth
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Samuel C. Wadsworth filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 07 May 2024.
Change
- Previous filing in this sequence was filed on 08 May 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,202
- Change %
- Price
- Shares after
- 4,202
- Date
- 04 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,202
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,202
- Exercise price
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents the vesting and settlement of Restricted Stock Units ("RSUs") on May 4, 2024.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F3
On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split.
Footnote F4
On May 4, 2023 the Reporting Person was granted RSUs. The RSUs vested in full on May 4, 2024.